0001513162-19-000226.txt : 20191024
0001513162-19-000226.hdr.sgml : 20191024
20191024200501
ACCESSION NUMBER: 0001513162-19-000226
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191023
FILED AS OF DATE: 20191024
DATE AS OF CHANGE: 20191024
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MONAHAN JOHN J
CENTRAL INDEX KEY: 0001257825
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37492
FILM NUMBER: 191167189
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anixa Biosciences Inc
CENTRAL INDEX KEY: 0000715446
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 112622630
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1031
BUSINESS ADDRESS:
STREET 1: 3150 ALMADEN EXPRESSWAY, SUITE 250
CITY: SAN JOSE
STATE: CA
ZIP: 95118
BUSINESS PHONE: 408-708-9808
MAIL ADDRESS:
STREET 1: 3150 ALMADEN EXPRESSWAY, SUITE 250
CITY: SAN JOSE
STATE: CA
ZIP: 95118
FORMER COMPANY:
FORMER CONFORMED NAME: ITUS Corp
DATE OF NAME CHANGE: 20140902
FORMER COMPANY:
FORMER CONFORMED NAME: COPYTELE INC
DATE OF NAME CHANGE: 19920703
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-10-23
0
0000715446
Anixa Biosciences Inc
ANIX
0001257825
MONAHAN JOHN J
C/O ANIXA BIOSCIENCES, INC.
3150 ALMADEN EXPRESSWAY, SUITE 250
SAN JOSE
CA
95118
1
0
0
0
Employee Stock Option (Right to Buy)
3.87
2019-10-23
4
A
0
45000
0
A
2029-10-23
Common Stock
45000
45000
D
Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
The options vest and become exercisable in twelve (12) equal monthly installments beginning November 30, 2019.
/s/ John J. Monahan
2019-10-24